Compound index

Incretin & Metabolic Receptor Agonists

Retatrutide

Also known as LY3437943

Late-stage human trialsInvestigational

Last reviewed: 2026-11-19

Class & structure

A 39-amino-acid chain.

Conceptual amino-acid chain · 39 residues in this molecule

How it’s thought to work

Activates GIP, GLP-1 and glucagon receptors; their combined effects are studied in controlled trials.

Molecule → target. A conceptual fit, not proof of a clinical effect.

Key sources

Identity and editorial screen completed November 19, 2026. Previously checked primary references retained; this is not an exhaustive clinical review.

Related compounds

  • Semaglutide

    Same scientific class · A 31-amino-acid chain. · FDA-approved for specific indications

  • Tirzepatide

    Same scientific class · A 39-amino-acid chain. · FDA-approved for specific indications

Related glossary terms